Page last updated: 2024-12-11

n-hydroxy-9-octadecenamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxy-9-octadecenamide: RN given refers to (9Z)-isomer; OA-Hy is the (cis)-isomer; a matrix metalloproteinase-2 inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436367
CHEMBL ID276537
SCHEMBL ID6891974
MeSH IDM0449570

Synonyms (20)

Synonym
n-hydroxyoleamide
oleoyl-n-hydroxylamide
mmp-2 inhibitor i
CHEMBL276537
(z)-n-hydroxyoctadec-9-enamide
n-hydroxyoleylamide
10335-69-0
9-octadecenoyl-n-hydroxylamide
oleylhydroxamic acid
n-hydroxy-9-octadecenamide
einecs 233-728-4
9-octadecenamide, n-hydroxy-, (9z)-
oa-hy cpd
SCHEMBL6891974
J-000946
mmp-2 inhibitor i - cas 10335-69-0
DTXSID80884461
(9z)-n-hydroxyoctadec-9-enamide
CS-0046343
HY-112546
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID196759Inhibition of rat glial cell gap junction at the concentration of 50 uM1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Arachidonic acid amide inhibitors of gap junction cell-cell communication.
AID1688844Inhibition of rat FAAH expressed in HEK293 cells using AEA as substrate at 100 uM by liquid chromatography/mass spectroscopy relative to control2020European journal of medicinal chemistry, Feb-15, Volume: 188A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]